Fusion Antibodies are delighted to be attending  the 17th Drug Discovery Innovation Programme.

Taling place in Munich on 5-6th October 2022,  experience 2-days of top-level strategic content and the current scientific insights, networking, and discussions from leading global pharmaceutical R&D executives.

With over 100+ attendees, learn how new technologies and innovative processes are fundamentally changing what the drug discovery research will look like in the next two to five years.

This year’s Drug Discovery Innovation Programme will highlight the challenges discovery pipelines have faced due to COVID-19 and will put a spotlight on the adoption of technology to combat these.

We are exhibiting at this event so pop over to stand 9 and say hello to the Fusion team.